{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:25:10Z","timestamp":1779153910881,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T00:00:00Z","timestamp":1486425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T00:00:00Z","timestamp":1486425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA013911"],"award-info":[{"award-number":["T32DA013911"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2230-2","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T11:11:17Z","timestamp":1486465877000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0665-5393","authenticated-orcid":false,"given":"Omowunmi","family":"Aibana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariya","family":"Bachmaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viatcheslav","family":"Krasiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Rybak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy P.","family":"Flanigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasyl","family":"Petrenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan B.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,7]]},"reference":[{"key":"2230_CR1","unstructured":"World Health Organization. Global tuberculosis report 2016. \n                    http:\/\/www.who.int\/tb\/publications\/global_report\/en\/\n                    \n                  . Accessed 20 Oct 2016."},{"key":"2230_CR2","unstructured":"World Health Organization. Tuberculosis country profiles. \n                    http:\/\/www.who.int\/tb\/country\/data\/profiles\/en\/\n                    \n                  . Accessed 20 Oct 2016."},{"issue":"7","key":"2230_CR3","doi-asserted-by":"publisher","first-page":"e20436","DOI":"10.1371\/journal.pone.0020436","volume":"6","author":"JE Farley","year":"2011","unstructured":"Farley JE, Ram M, Pan W, Waldman S, Cassell GH, Chaisson RE, et al. Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence. PLoS One. 2011;6(7):e20436.","journal-title":"PLoS One"},{"issue":"4","key":"2230_CR4","first-page":"413","volume":"14","author":"JC Brust","year":"2010","unstructured":"Brust JC, Gandhi NR, Carrara H, Osburn G, Padayatchi N. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000\u20132003. Int J Tuberc Lung Dis. 2010;14(4):413\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"2230_CR5","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1183\/09031936.00155708","volume":"33","author":"K Kliiman","year":"2009","unstructured":"Kliiman K, Altraja A. Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB. Eur Respir J. 2009;33(5):1085\u201394.","journal-title":"Eur Respir J"},{"issue":"5","key":"2230_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tube.2012.06.003","volume":"92","author":"EV Kurbatova","year":"2012","unstructured":"Kurbatova EV, Taylor A, Gammino VM, Bayona J, Becerra M, Danilovitz M, et al. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. Tuberculosis (Edinb). 2012;92(5):397\u2013403.","journal-title":"Tuberculosis (Edinb)"},{"issue":"9","key":"2230_CR7","doi-asserted-by":"publisher","first-page":"e6914","DOI":"10.1371\/journal.pone.0006914","volume":"4","author":"JC Johnston","year":"2009","unstructured":"Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One. 2009;4(9):e6914.","journal-title":"PLoS One"},{"issue":"4","key":"2230_CR8","first-page":"402","volume":"10","author":"SS Shin","year":"2006","unstructured":"Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, et al. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis. 2006;10(4):402\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"2230_CR9","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1086\/588292","volume":"46","author":"MF Franke","year":"2008","unstructured":"Franke MF, Appleton SC, Bayona J, Arteaga F, Palacios E, Llaro K, et al. Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment. Clin Infect Dis. 2008;46(12):1844\u201351.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2230_CR10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.5588\/ijtld.11.0795","volume":"16","author":"AC Miller","year":"2012","unstructured":"Miller AC, Gelmanova IY, Keshavjee S, Atwood S, Yanova G, Mishustin S, et al. Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation. Int J Tuberc Lung Dis. 2012;16(7):891\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"2230_CR11","doi-asserted-by":"publisher","first-page":"e46943","DOI":"10.1371\/journal.pone.0046943","volume":"7","author":"H Satti","year":"2012","unstructured":"Satti H, McLaughlin MM, Hedt-Gauthier B, Atwood SS, Omotayo DB, Ntlamelle L, et al. Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho. PLoS One. 2012;7(10):e46943.","journal-title":"PLoS One"},{"issue":"3","key":"2230_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.5588\/ijtld.11.0473","volume":"16","author":"E Palacios","year":"2012","unstructured":"Palacios E, Franke M, Mu\u00f1oz M, Hurtado R, Dallman R, Chalco K, et al. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era. Int J Tuberc Lung Dis. 2012;16(3):348\u201354.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"2230_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1473-3099(09)70041-6","volume":"9","author":"EW Orenstein","year":"2009","unstructured":"Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009;9(3):153\u201361.","journal-title":"Lancet Infect Dis"},{"key":"2230_CR14","unstructured":"Ministry of Health of Ukraine, Unified Clinical Protocol for Primary, Secondary (Specialized) and Tertiary (Highly Specialized) Medical Care for Adults with Tuberculosis. 04 September 2014. \n                    http:\/\/moz.gov.ua\/docfiles\/dn_20140904_0620_dod.pdf\n                    \n                  . Accessed 23 Nov 2014."},{"key":"2230_CR15","volume-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. 2014. Available at: \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/130918\/1\/9789241548809_eng.pdf?ua=1&ua=1\n                    \n                  . Accessed 15 Nov 2015."},{"issue":"Suppl 2","key":"2230_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5588\/pha.14.0042","volume":"4","author":"A Khaliaukin","year":"2014","unstructured":"Khaliaukin A, Kumar AM, Skrahina A, Hurevich H, Rusovich V, Gadoev J, et al. Poor treatment outcomes among multidrug-resistant tuberculosis patients in Gomel Region, Republic of Belarus. Public Health Action. 2014;4 Suppl 2:24\u20138.","journal-title":"Public Health Action"},{"issue":"Suppl 2","key":"2230_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5588\/pha.14.0043","volume":"4","author":"O Dolgusev","year":"2014","unstructured":"Dolgusev O, Obevzenco N, Padalco O, Pankrushev S, Ramsay A, Van den Bergh R, et al. Pattern of primary tuberculosis drug resistance and associated treatment outcomes in Transnistria, Moldova. Public Health Action. 2014;4 Suppl 2:64\u20136.","journal-title":"Public Health Action"},{"issue":"Suppl 2","key":"2230_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5588\/pha.14.0041","volume":"4","author":"L Kuksa","year":"2014","unstructured":"Kuksa L, Riekstina V, Leimane V, Ozere I, Skenders G, Van den Bergh R, et al. Multi- and extensively drug-resistant tuberculosis in Latvia: trends, characteristics and treatment outcomes. Public Health Action. 2014;4 Suppl 2:47\u201353.","journal-title":"Public Health Action"},{"issue":"9647","key":"2230_CR19","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(08)61204-0","volume":"372","author":"S Keshavjee","year":"2008","unstructured":"Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet. 2008;372(9647):1403\u20139.","journal-title":"Lancet"},{"issue":"Suppl 2","key":"2230_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5588\/pha.14.0035","volume":"4","author":"N Lytvynenko","year":"2014","unstructured":"Lytvynenko N, Cherenko S, Feschenko Y, Pogrebna M, Senko Y, Barbova A, et al. Management of multi- and extensively drug-resistant tuberculosis in Ukraine: how well are we doing? Public Health Action. 2014;4 Suppl 2:67\u201372.","journal-title":"Public Health Action"},{"issue":"1","key":"2230_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5588\/ijtld.11.0153","volume":"16","author":"NR Gandhi","year":"2012","unstructured":"Gandhi NR, Andrews JR, Brust JC, Montreuil R, Weissman D, Heo M, et al. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2012;16(1):90\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"2230_CR22","doi-asserted-by":"publisher","first-page":"e0142873","DOI":"10.1371\/journal.pone.0142873","volume":"10","author":"JF Daniels","year":"2015","unstructured":"Daniels JF, Khogali M, Mohr E, Cox V, Moyo S, Edginton M, et al. Time to ART initiation among patients treated for rifampicin-resistant tuberculosis in Khayelitsha, South Africa: impact on mortality and treatment success. PLoS One. 2015;10(11):e0142873.","journal-title":"PLoS One"},{"issue":"1","key":"2230_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/cid\/ciu209","volume":"59","author":"GE Vel\u00e1squez","year":"2014","unstructured":"Vel\u00e1squez GE, Becerra MC, Gelmanova IY, Pasechnikov AD, Yedilbayev A, Shin SS, et al. Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death. Clin Infect Dis. 2014;59(1):9\u201315.","journal-title":"Clin Infect Dis"},{"key":"2230_CR24","doi-asserted-by":"publisher","first-page":"e58664","DOI":"10.1371\/journal.pone.0058664","volume":"8","author":"CD Mitnick","year":"2013","unstructured":"Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, et al. Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLoS One. 2013;8:e58664.","journal-title":"PLoS One"},{"issue":"6","key":"2230_CR25","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/cid\/cis1008","volume":"56","author":"MF Franke","year":"2013","unstructured":"Franke MF, Appleton SC, Mitnick CD, Furin JJ, Bayona J, Chalco K, et al. Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence. Clin Infect Dis. 2013;56(6):770\u20136.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2230_CR26","doi-asserted-by":"publisher","first-page":"e1\u20137","DOI":"10.1097\/QAI.0000000000001110","volume":"73","author":"N Padayatchi","year":"2016","unstructured":"Padayatchi N, Naidu N, Yende-Zuma N, O\u2019Donnell MR, Naidoo K, Augustine S, et al. Implementation and operational research: clinical impact of the Xpert MTB\/RIF assay in patients With multidrug-resistant tuberculosis. J Acquir Immune Defic Syndr. 2016;73(1):e1\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 2","key":"2230_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5588\/pha.14.0047","volume":"4","author":"A Ciobanu","year":"2014","unstructured":"Ciobanu A, Domente L, Soltan V, Bivol S, Severin L, Plesca V, et al. Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova? Public Health Action. 2014;4 Suppl 2:59\u201363.","journal-title":"Public Health Action"},{"issue":"10","key":"2230_CR28","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.5588\/ijtld.10.0531","volume":"15","author":"IY Gelmanova","year":"2011","unstructured":"Gelmanova IY, Taran DV, Mishustin SP, Golubkov AA, Solovyova AV, Keshavjee S. \u2018Sputnik\u2019: a programmatic approach to improve tuberculosis treatment adherence and outcome among defaulters. Int J Tuberc Lung Dis. 2011;15(10):1373\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"2230_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5588\/ijtld.12.0537","volume":"17","author":"A Toczek","year":"2013","unstructured":"Toczek A, Cox H, du Cros P, Cooke G, Ford N. Strategies for reducing treatment default in drug-resistant tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2013;17(3):299\u2013307.","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2230-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-017-2230-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2230-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T11:16:09Z","timestamp":1589454969000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2230-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2230"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2230-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,7]]},"assertion":[{"value":"29 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"129"}}